Stay updated with breaking news from New Share. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics is pleased to announce that it has received firm commitments from new and existing institutional investors for a non-underwritten placement of 8.6 million new fully paid ordinary shares.
Proteomics International Laboratories Ltd , a pioneer in predictive diagnostics is pleased to announce that it has received firm commitments from new and existing institutional investors for a...
Company announcement – No. 1 / 2024 Zealand Pharma announces directed issue and private placement for gross proceeds of DKK 1.45 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES AND THE SECURITIES REFERRED TO HEREIN MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION EXC
Funding will be utilized for a well test on natural gas discoveries in the Upper and Lower Angwa formations in Mukuyu-2 well, preparation for 3D seismic over the Mukuyu gas field and long lead items for a planned high impact exploration well from the company’s extensive portfolio in the Basin Margin or Central Fairway prospects.
MorphoSys AG / Key word(s): Capital IncreaseAd hoc: MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process13-Dec-2023 / 22:01 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The...